Table 1.
Characteristics of PERTINENT study sites, vaccination strategy during pregnancy, in adulthood, primary schedule in infants, Europe, 1 December 2015–31 December 2019.
| Study sites | Vaccination strategy |
Number of participating hospitals | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Pregnancy |
Cocooning |
Adult | Primary schedule in infants (age in months) |
||||||
| Year of introduction | Gestational age (in weeks) | Estimated vaccination coverage | Year of introduction | 1st dose | 2nd dose | 3rd dose | |||
| Czech Republic | 2016 | 28–36 | 1.6% in 2021 a | No | At least once | 3 b | 5 b | 11–13b | 6 |
| Ireland | 2013 | 16–36 | 49.9% in 2017/2018 [11] | 2013 | No | 2 | 4 | 6 | 2 |
| Italy | 2017 | ≥ 27 | NA | No | Every 10 years | 3 | 5 | 11 | 1 |
| Spain, Catalonia | 2014 | 27–36 | 82.8% in 2019 [12] | No | No | 2 c | 4 c | 11c | 1 |
| Spain, Navarra | 2015 | 27–36 | 91.1% in 2019 [12] | No | No | 2 c | 4 c | 11c | 4 |
NA: not available.
a
Estimates from the final report of the project “Monitoring the vaccination of pregnant women against pertussis and influenza, 2020–2021” financed from NIPH Prague internal institutional funds. In this pilot prospective observational hospital-based study in the maternity hospital in Prague, 4617 women (84%) were included in the analysis out of the 5475 women who gave birth in 2021.
b
Before 2018: doses at 2, 3, 4 and 10 months.
c
Before 2016: doses at 2, 4 and 6 months.